White matter hyperintensities are associated with locus coeruleus atrophy and astrocytic β 2 -adrenergic receptor expression.
Victor Vidal, Gonzalo Farías, Carolina Delgado, Paul H Delano et al.
Kernaussage
Locus coeruleus (LC) atrophy is significantly associated with both the overall burden and the spatial distribution of white matter hyperintensities (WMHs) in aging, and this association is mediated by cortical β2-adrenergic receptor (ADRB2) expression, suggesting a neuromodulatory pathway contributing to white matter vulnerability.
Abstract
White matter hyperintensities (WMHs) are a robust marker of brain aging and dementia risk, typically attributed to vascular pathology. However, impaired astrocytic support may also contribute. The locus coeruleus (LC), which degenerates early in aging and Alzheimer's disease, provides widespread noradrenergic projections that regulate astrocytic metabolism via β 2 -adrenergic signaling. In a healthy aging cohort (N = 106), we quantified LC volume, WMHs, and voxel-wise (q-WMHs). Associations were tested, controlling for age, cardiovascular risk, and other subcortical nuclei. Spatial partial least squares regression related q-WMH patterns to LC volume, age, and cortical adrenergic receptor expression. LC volume was independently associated with WMH burden and mediated age-related WMH increases. A latent q-WMH pattern aligned with cortical β 2 -adrenergic receptor expression and mediated its association with WMH burden. LC degeneration may contribute to regional WMH vulnerability through noradrenergic mechanisms consistent with astrocytic β 2 -adrenergic signaling, highlighting a potential nonvascular pathway influencing white matter integrity.
Kein medizinischer Rat. Die dargestellten Studien dienen der wissenschaftlichen Information und ersetzen keine ärztliche Beratung. Bei gesundheitlichen Fragen wende dich an eine approbierte Ärztin oder einen Arzt.
Quelle: PubMed Central / National Library of Medicine (NLM). Apollion steht in keiner Verbindung mit NLM und wird von NLM nicht empfohlen. Evidenzgrade bewerten die methodische Studienqualität — nicht die inhaltliche Richtigkeit.
Lizenz: CC BY — Inhalte werden ausschließlich aus Open-Access-Quellen mit kommerziell nutzbaren Lizenzen (CC0, CC BY, CC BY-SA) indexiert.